Legal Representation
Attorney
Lisa M. Tittemore
USPTO Deadlines
Next Deadline
0 days remaining
Non-Final Action Mailed
Due Date
November 05, 2025
Extension Available
Until February 05, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 29, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 5, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 5, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 5, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 21, 2025 | PMSG | O | PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED | Loading... |
| Jul 14, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jun 16, 2025 | TPMS | I | TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED | Loading... |
| May 5, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 5, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 5, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Therapeutic agents, namely pharmaceutical preparations for the treatment of atopic dermatitis, asthma, chronic obstructive pulmonary disease, prurigo nodularis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, bullous pemphigoid, chronic spontaneous urticaria, lupus, Sjogren's Syndrome, rheumatoid arthritis, inflammatory bowel disease, and dermatomyositis
First Use Anywhere:
20241000
First Use in Commerce:
20241000
Additional Information
Pseudo Mark
K T;KYMERA THERAPEUTICS
Classification
International Classes
005